Uveal melanoma: trends in incidence, treatment, and survival, Ophthalmology, vol.118, issue.9, pp.1881-1885, 2011. ,
Very long-term prognosis of patients with malignant uveal melanoma, Invest Ophthalmol Vis Sci, vol.44, issue.11, pp.4651-4659, 2003. ,
Screening for metastasis from choroidal melanoma: the collaborative ocular melanoma study group report 23, J Clin Oncol, vol.22, issue.12, pp.2438-2444, 2004. ,
, Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the collaborative ocular melanoma study (COMS): COMS report no. 15, Arch Ophthalmol, vol.119, pp.670-676, 2001.
Molecular pathology of uveal melanoma, Eye (Lond), vol.27, issue.2, pp.230-242, 2013. ,
Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma, Ophthalmology, vol.119, issue.8, pp.1596-1603, 2012. ,
PRAME as an independent biomarker for metastasis in uveal melanoma, Clin Cancer Res, vol.22, issue.5, pp.1234-1242, 2016. ,
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3, Nat Genet, vol.45, issue.8, pp.933-936, 2013. ,
Frequent mutation of BAP1 in metastasizing uveal melanomas, Science, vol.330, issue.6009, pp.1410-1413, 2010. ,
Recurrent activating mutations of Gprotein-coupled receptor CYSLTR2 in uveal melanoma, Nat Genet, vol.48, issue.6, pp.675-680, 2016. ,
Effectiveness of treatments for metastatic uveal melanoma, Am J Ophthalmol, vol.148, issue.1, pp.119-127, 2009. ,
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial, JAMA, vol.311, issue.23, pp.2397-2405, 2014. ,
Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and followup, Ann Oncol, vol.26, issue.5, pp.126-132, 2015. ,
Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: a phase III, multicenter, randomized trial (SUMIT), J Clin Oncol, vol.36, issue.12, pp.1232-1239, 2018. ,
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives, Cancer Med, vol.2, issue.5, pp.674-686, 2013. ,
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative ocular melanoma study group report no, Arch Ophthalmol, vol.123, issue.26, pp.1639-1643, 2005. ,
The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection, J Surg Oncol, vol.109, issue.6, pp.542-547, 2014. ,
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials, J Clin Oncol, vol.26, issue.4, pp.527-534, 2008. ,
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, vol.339, p.2535, 2009. ,
AJCC Cancer Staging Manual, 2009. ,
Sample size tables for exact single-stage phase II designs, Stat Med, vol.20, issue.6, pp.859-866, 2001. ,
Sample Size Calculations in Clinical Research, 2008. ,
Statistical Methods for Rates and Proportions, 2003. ,
, , 2000.
Sample Size Tables for Clinical Studies, 1997. ,
Sample Size Determination and Power, 2013. ,
Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients, Am J Ophthalmol, vol.158, issue.5, pp.939-947, 2014. ,
A phase 2 study of tremelimumab in patients with advanced uveal melanoma, Melanoma Res, vol.25, issue.4, pp.342-347, 2015. ,
Phase II study evaluating ipilimumab as a single agent in the first-line treatment of adult patients (Pts) with metastatic uveal melanoma (MUM): the GEM-1 trial, J Clin Oncol, vol.32, p.9033, 2014. ,
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naive patients with metastatic uveal melanoma, PLoS One, vol.10, issue.3, p.118564, 2015. ,
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma, Eur J Cancer, vol.39, pp.1115-1120, 2003. ,
A cancer research UK two-stage multicenter phase II study of imatinib in the treatment of patients with c-kit positive metastatic uveal melanoma (ITEM), ASCO Meeting Abstr, vol.30, p.8523, 2012. ,
A pilot study of sunitinib malate in patients with metastatic uveal melanoma, Melanoma Res, vol.22, issue.6, pp.440-446, 2012. ,
O-Mel-Inib: a Cancero-pole Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma, Invest New Drugs, vol.26, issue.6, pp.561-565, 2008. ,
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512, PLoS One, vol.7, issue.11, p.48787, 2012. ,
Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study, Br J Cancer, vol.115, issue.1, pp.20-24, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01481462
Aflibercept (VEGF trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin, Clin Cancer Res, vol.17, issue.20, pp.6574-6581, 2011. ,
Phase II trial of bevacizumab in combination with temozolomide as first-line treatment in patients with metastatic uveal melanoma, Oncologist, vol.21, issue.3, pp.281-282, 2016. ,
Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study, Anticancer Drugs, vol.14, pp.337-340, 2003. ,
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial, Ann Oncol, vol.25, issue.3, pp.742-746, 2014. ,
Phase II evaluation of temozolomide in metastatic choroidal melanoma, Melanoma Res, vol.13, issue.3, pp.303-306, 2003. ,
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma, Melanoma Res, vol.20, issue.6, pp.507-510, 2010. ,
A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours, Eur J Cancer, vol.40, issue.14, pp.2047-2052, 2004. ,
A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma, Ann Oncol, vol.17, issue.12, pp.1826-1829, 2006. ,
A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma, Melanoma Res, vol.15, issue.5, pp.447-451, 2005. ,
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocytemacrophage colony-stimulating factor, J Clin Oncol, vol.26, issue.33, pp.5436-5442, 2008. ,
Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases, Ann Surg Oncol, vol.15, pp.1891-1898, 2008. ,
Transarterial chemoembolization of liver metastases in patients with uveal melanoma, Eur J Radiol, vol.74, issue.3, pp.38-44, 2010. ,
Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study, Melanoma Res, vol.15, issue.4, pp.297-304, 2005. ,
Double-blinded, randomized phase II study using embolization with or without granulocytemacrophage colony-stimulating factor in uveal melanoma with hepatic metastases, J Vasc Interv Radiol, vol.26, issue.4, pp.523-532, 2015. ,
Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival, J Cancer Res Clin Oncol, vol.133, issue.3, pp.177-184, 2007. ,
Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study, In Vivo, vol.23, pp.131-137, 2009. ,
Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients, J Clin Oncol, vol.26, issue.4, pp.517-518, 2008. ,
Development and external validation of a prognostic nomogram for metastatic uveal melanoma, PLoS One, vol.10, issue.3, p.120181, 2015. ,
A prognostic model and staging for metastatic uveal melanoma, Cancer, vol.97, issue.2, pp.465-475, 2003. ,
Validation of a prognostic staging for metastatic uveal melanoma: a collaborative study of the European Ophthalmic Oncology Group, Am J Ophthalmol, vol.168, pp.217-226, 2016. ,
Variates of survival in metastatic uveal melanoma, J Clin Oncol, vol.23, issue.31, pp.8076-8080, 2005. ,